WO2007138468A3 - Processes for the preparation of lansoprazole - Google Patents
Processes for the preparation of lansoprazole Download PDFInfo
- Publication number
- WO2007138468A3 WO2007138468A3 PCT/IB2007/001437 IB2007001437W WO2007138468A3 WO 2007138468 A3 WO2007138468 A3 WO 2007138468A3 IB 2007001437 W IB2007001437 W IB 2007001437W WO 2007138468 A3 WO2007138468 A3 WO 2007138468A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- preparation
- lansoprazole
- processes
- relates
- pure lansoprazole
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention relates to processes for the preparation of benzimidazole sulphinyl compounds. More particularly, it relates to the preparation of pure lansoprazole and pharmaceutical compositions that include the pure lansoprazole.
Applications Claiming Priority (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN838MU2006 | 2006-06-01 | ||
IN835MU2006 | 2006-06-01 | ||
IN837MU2006 | 2006-06-01 | ||
IN854/MUM/2006 | 2006-06-01 | ||
IN854MU2006 | 2006-06-01 | ||
IN846MU2006 | 2006-06-01 | ||
IN837/MUM/2006 | 2006-06-01 | ||
IN835/MUM/2006 | 2006-06-01 | ||
IN846/MUM/2006 | 2006-06-01 | ||
IN838/MUM/2006 | 2006-06-01 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007138468A2 WO2007138468A2 (en) | 2007-12-06 |
WO2007138468A3 true WO2007138468A3 (en) | 2009-04-23 |
Family
ID=38779051
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2007/001437 WO2007138468A2 (en) | 2006-06-01 | 2007-05-31 | Processes for the preparation of lansoprazole |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2007138468A2 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010095144A2 (en) * | 2009-02-04 | 2010-08-26 | Msn Laboratories Limited | Process for the preparation of proton pump inhibitors |
CN102558148A (en) * | 2010-12-15 | 2012-07-11 | 山东方明药业股份有限公司 | Synthesis process of lansoprazole important intermediate |
CN102617555B (en) * | 2012-03-20 | 2014-05-21 | 北京易明康元医药科技有限公司 | Preparation method of lansoprazole |
CN104327048A (en) * | 2014-04-04 | 2015-02-04 | 苏州东瑞制药有限公司 | Lansoprazole thioether crystal form, and preparation method and application thereof |
CN104483403B (en) * | 2014-12-05 | 2016-06-01 | 广东东阳光药业有限公司 | A kind of detect the method that R-lansoprazole bulk drug has related substance |
CN104530006B (en) * | 2015-01-06 | 2018-05-11 | 江苏奥赛康药业股份有限公司 | The preparation method of Lansoprazole |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6245913B1 (en) * | 1999-06-30 | 2001-06-12 | Wockhardt Europe Limited | Synthetic procedure for 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methylthio]-IH-benzimidazole hydrochloride and its conversion to omeprazole |
US20040209918A1 (en) * | 2001-07-16 | 2004-10-21 | Broeckx Rudy Laurent Maria | Process for preparing benzimidazole-type compounds |
-
2007
- 2007-05-31 WO PCT/IB2007/001437 patent/WO2007138468A2/en active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6245913B1 (en) * | 1999-06-30 | 2001-06-12 | Wockhardt Europe Limited | Synthetic procedure for 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methylthio]-IH-benzimidazole hydrochloride and its conversion to omeprazole |
US20040209918A1 (en) * | 2001-07-16 | 2004-10-21 | Broeckx Rudy Laurent Maria | Process for preparing benzimidazole-type compounds |
Non-Patent Citations (1)
Title |
---|
XIE ET AL.: "Biotransformation of pantoprazole by the fungus cunninghamella blaksleeana", XENOBIOTICA, vol. 35, 2005, pages 467 - 477 * |
Also Published As
Publication number | Publication date |
---|---|
WO2007138468A2 (en) | 2007-12-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2251038A4 (en) | Solid dispersion, pharmaceutical compositions containing the same, and processes for the production of both | |
WO2008049116A3 (en) | Substituted indoles | |
WO2009152356A3 (en) | Compounds and compositions useful for the treatment of malaria | |
WO2007109605A3 (en) | Pharmaceutical compositions | |
WO2008021851A3 (en) | Novel compounds as antagonists or inverse agonists for opioid receptors | |
WO2007146965A3 (en) | Compounds for the treatment of periodontal disease | |
WO2008013838A3 (en) | Pyridizinone derivatives | |
WO2009067686A3 (en) | Sunitinib hemi-l-malate, polymorphs and preparation thereof, polymorphs of racemic sunitinib malate, compositins containing sunitinib base and malic acid and preparation thereof | |
WO2010069532A8 (en) | Antibodies against human angiopoietin 2 | |
EP2045251A4 (en) | Compound that can inhibit ubc13-uev interactions, pharmaceutical compositions and therapeutic uses | |
WO2009121039A3 (en) | Administration of benzodiazepine compositions | |
WO2008115281A3 (en) | Compounds for treating viral infections | |
WO2010039977A3 (en) | Heteroaryl antagonists of prostaglandin d2 receptors | |
WO2008035373A3 (en) | Highly pure polysialic acid and process for preperation thereof | |
WO2006002077A3 (en) | Stable pharmaceutical formulations of benzimidazole compounds | |
IL210549A (en) | Substituted- quinoxaline-type bridged-piperidine compounds, compositions comprising them and uses thereof for the manufacture of medicaments | |
HK1104795A1 (en) | Dry formulations of aripiprazole | |
WO2008027600A3 (en) | Imatinib compositions | |
WO2009071689A3 (en) | 5-halogen-substituted oxindole derivatives and use thereof for treating vasopressine-dependent diseases | |
WO2008088779A3 (en) | Solid state forms of 5-azacytidine and processes for preparation thereof | |
WO2009114461A3 (en) | Angiotensin (1-7) dosage forms and uses thereof | |
WO2009115084A3 (en) | Pyrrolopyrimidine derivatives, and use thereof | |
WO2010049449A3 (en) | Novel salts of sunitinib | |
WO2008001201A3 (en) | Pharmaceutical compositions of clopidogrel | |
WO2009094457A3 (en) | Substituted benzhydrylethers |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07766508 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
NENP | Non-entry into the national phase |
Ref country code: RU |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 07766508 Country of ref document: EP Kind code of ref document: A2 |